| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092371251 |
| P356 | DOI | 10.1038/S41598-017-14690-5 |
| P932 | PMC publication ID | 5660197 |
| P698 | PubMed publication ID | 29079845 |
| P50 | author | Robert Weinkove | Q41593344 |
| Axel Heiser | Q57195273 | ||
| Ian F Hermans | Q57555897 | ||
| Collin R Brooks | Q59681868 | ||
| Benjamin J Compton | Q62237207 | ||
| Mary Speir | Q86934098 | ||
| P2093 | author name string | J A Berzofsky | |
| R J Anderson | |||
| C W Tang | |||
| M Terabe | |||
| A Authier-Hall | |||
| G F Painter | |||
| K J Farrand | |||
| T L Osmond | |||
| P2860 | cites work | The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation | Q36402640 |
| Application of tissue engineering to the immune system: development of artificial lymph nodes | Q38060720 | ||
| Cancer vaccine adjuvants--recent clinical progress and future perspectives | Q38260496 | ||
| NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity | Q38412832 | ||
| A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy. | Q38418416 | ||
| Vaccines for established cancer: overcoming the challenges posed by immune evasion | Q38769021 | ||
| Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire | Q38927379 | ||
| Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination | Q39049093 | ||
| Immune targets and neoantigens for cancer immunotherapy and precision medicine | Q39057617 | ||
| High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses | Q40259645 | ||
| NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells | Q40618321 | ||
| Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants | Q40871585 | ||
| Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma. | Q40889921 | ||
| Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response. | Q40949444 | ||
| The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells | Q41815553 | ||
| IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset | Q42141575 | ||
| Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein | Q43566276 | ||
| A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 | ||
| Role of 4-1BB in immune responses | Q48766099 | ||
| Adjuvants: Classification, Modus Operandi, and Licensing | Q26747586 | ||
| Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents | Q26748456 | ||
| Vaccine adjuvants as potential cancer immunotherapeutics | Q26752522 | ||
| The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation | Q26797344 | ||
| A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes | Q28219495 | ||
| TNF/TNFR family members in costimulation of T cell responses | Q28240053 | ||
| CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 | ||
| Apolipoprotein-mediated pathways of lipid antigen presentation | Q28275773 | ||
| CD1 recognition by mouse NK1+ T lymphocytes | Q28591238 | ||
| The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells | Q28593372 | ||
| Virus-specific T cells as correlate of (cross-)protective immunity against influenza. | Q30369605 | ||
| Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. | Q30374900 | ||
| Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control | Q30444800 | ||
| A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach | Q33326976 | ||
| Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells | Q33476079 | ||
| Modulation of the immune response through 4-1BB. | Q33918333 | ||
| Glycolipid antigen induces long-term natural killer T cell anergy in mice | Q33930869 | ||
| Advances in the study of HLA-restricted epitope vaccines | Q34170130 | ||
| Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation | Q34245351 | ||
| Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection | Q34287659 | ||
| Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity | Q34491896 | ||
| Infection history determines the differentiation state of human CD8+ T cells | Q35488692 | ||
| The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response | Q36031220 | ||
| Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) Vaccination | Q36237622 | ||
| Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function | Q36371748 | ||
| Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. | Q54439509 | ||
| Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death | Q56908523 | ||
| Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies | Q60489534 | ||
| Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein | Q77180605 | ||
| Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal | Q77399210 | ||
| A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system | Q77929123 | ||
| CD1-dependent dendritic cell instruction | Q78471073 | ||
| A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors | Q78632792 | ||
| Dendritic cell KLH loading requirements for efficient CD4+ T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines | Q78840786 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 14273 | |
| P577 | publication date | 2017-10-27 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins | |
| P478 | volume | 7 |
Search more.